Status | Study |
Not yet recruiting |
Study Name: Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation Condition: Hepatic Angiosarcoma Date: 2017-01-16 |
Recruiting |
Study Name: Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Condition: Metastatic Angiosarcoma Metastatic Epithelioid Sarcoma Date: 2016-12-05 Interventions: Drug: Doxorubicin Given IV |
Recruiting |
Study Name: A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA Condition: Advanced Angiosarcoma Date: 2016-11-29 Interventions: Biological: TRC105 Other Names |
Not yet recruiting |
Study Name: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) Condition: Angiosarcoma Date: 2016-03-29 Interventions: Drug: PROPRANOLOL |
Not yet recruiting |
Study Name: Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. Condition: Congenital Hemangioma Hemangioendothelioma Date: 2015-12-03 Interventions: Drug: Lipiodol® Ultra Fluid with surgical glues Lipiodol® Ultra Fluid and surgical glue mixtur |
Recruiting |
Study Name: Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma, Soft Tissue Soft Tissue Sarcoma Undifferentiated Date: 2015-10-12 Interventions: Drug: Dexrazoxane Other Names: |
Recruiting |
Study Name: Evaluation of Votrient in Angiosarcoma Condition: Angiosarcoma Date: 2014-07-29 Interventions: Drug: Pazopanib + Paclitaxel pazopanib in combination with paclitaxel in the treatment of patients with |
Recruiting |
Study Name: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Condition: Adult Angiosarcoma Recurrent Adult Soft Tissue Sarcoma Date: 2014-01-22 Interventions: Drug: regorafenib Given PO Other Names: |
Active, not recruiting |
Study Name: Identification, Molecular Epidemiology Angiosarcoma of the Liver France Condition: Angiosarcoma Date: 2013-02-06 Interventions: Biological: blood and urine Bl |
Completed |
Study Name: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery Condition: Adult Angiosarcoma Recurrent Adult Soft Tissue Sarcoma Date: 2012-06-17 Interventions: Other: Laboratory Biomarker Analysis |